Cell death in leukemia: Passenger protein regulation by topoisomerase inhibitors

被引:3
作者
Jahnke, Ulrike
Higginbottom, Karen
Newland, Adrian C.
Cotter, Finbarr E.
Allen, Paul D.
机构
[1] Queen Marys Univ London, Ctr Haematol, Inst Cell & Mol Sci Barts, London E1 2AT, England
[2] Queen Marys Univ London, London Sch Med & Dent, London E1 2AT, England
关键词
leukemia; mitotic catastrophe; apoptosis; Aurora B; survivin; Cdk1;
D O I
10.1016/j.bbrc.2007.07.117
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Etoposide is a potent inducer of mitotic catastrophe; a type of cell death resulting from aberrant mitosis. It is important in p53 negative cells where p53 dependent apoptosis and events at the G1 and G2 cell cycle checkpoints are compromised. Passenger proteins regulate many aspects of mitosis and siRNA interference or direct inhibition of Aurora B kinase results in mitotic catastrophe. However, there is little available data of clinical relevance in leukaemia models. Here, in p53 negative K562 myeloid leukemia cells, etoposide-induced mitotic catastrophe is shown to be time and/or concentration dependent. Survivin and Aurora remained bound to chromosomes. Survivin and Aurora were also associated with CdkI and were shown to form complexes, which in pull down experiments, included INCENP. There was no evidence of Aurora B kinase suppression. These data suggests etoposide will complement Aurora B kinase inhibitors currently in clinical trials for cancer. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:928 / 933
页数:6
相关论文
共 16 条
[1]   Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment [J].
Borgne, A. ;
Versteege, I. ;
Mahe, M. ;
Studeny, A. ;
Leonce, S. ;
Naime, I. ;
Rodriguez, M. ;
Hickman, J. A. ;
Meijer, L. ;
Golsteyn, R. M. .
ONCOGENE, 2006, 25 (56) :7361-7372
[2]   Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype [J].
Eom, YW ;
Kim, MA ;
Park, SS ;
Goo, MJ ;
Kwon, HJ ;
Sohn, S ;
Kim, WH ;
Yoon, G ;
Choi, KS .
ONCOGENE, 2005, 24 (30) :4765-4777
[3]   Validating Aurora B as an anti-cancer drug target [J].
Girdler, Fiona ;
Gascoigne, Karen E. ;
Eyers, Patrick A. ;
Hartmuth, Sonya ;
Crafter, Claire ;
Foote, Kevin M. ;
Keen, Nicholas J. ;
Taylor, Stephen S. .
JOURNAL OF CELL SCIENCE, 2006, 119 (17) :3664-3675
[4]   Etoposide-mediated deregulation of the G2M checkpoint in myeloid leukaemic cell lines results in loss of cell survival [J].
Higginbottom, K ;
Cummings, M ;
Newland, AC ;
Allen, PD .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (04) :956-964
[5]  
Kaufmann WK, 1998, P SOC EXP BIOL MED, V217, P327
[6]   Aurora-kinase inhibitors as anticancer agents [J].
Keen, N ;
Taylor, S .
NATURE REVIEWS CANCER, 2004, 4 (12) :927-936
[7]  
Lock RB, 1996, CANCER RES, V56, P4006
[8]   Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis [J].
Martins, LM ;
Kottke, TJ ;
Kaufmann, SH ;
Earnshaw, WC .
BLOOD, 1998, 92 (09) :3042-3049
[9]   Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis [J].
Murata-Hori, M ;
Tatsuka, M ;
Wang, YL .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (04) :1099-1108
[10]   Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin [J].
O'Connor, DS ;
Grossman, D ;
Plescia, J ;
Li, FZ ;
Zhang, H ;
Villa, A ;
Tognin, S ;
Marchisio, PC ;
Altieri, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13103-13107